Complete financial analysis of Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Hisun Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Corporativo GBM, S.A.B. de C.V. (GBMO.MX) Income Statement Analysis – Financial Results
- Investeringsforeningen Jutlanderinvest – Offensiv (SDIOFF.CO) Income Statement Analysis – Financial Results
- Philip Morris International Inc. (PMI.SW) Income Statement Analysis – Financial Results
- TRADE WORKS Co., Ltd (3997.T) Income Statement Analysis – Financial Results
- Falabella S.A. (FALABELLA.SN) Income Statement Analysis – Financial Results
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hisunpharm.com
About Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd. manufactures and supplies pharmaceutical products in China. It provides active pharmaceutical ingredients and finished dosage form products. The company offers products in the areas of anti-tumor, cardiovascular, anti-infective, liver care, orthopedics, anticancer, anti-parasitic, immunosuppressant, etc.; and weight loss, anti-viral, anti-TB, veterinary pharma, and others. It also provides product consultation and CMO/CRO manufacturing services. The company was founded in 1956 and is headquartered in Taizhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.37B | 12.04B | 12.14B | 11.35B | 11.07B | 10.19B | 10.57B | 9.73B | 8.77B | 10.10B | 8.60B | 5.80B | 5.16B | 4.54B | 4.00B | 3.18B | 2.84B | 2.26B | 1.91B | 1.78B | 1.55B | 762.32M | 575.83M | 518.00M | 357.91M | 283.66M | 269.56M |
| Cost of Revenue | 6.19B | 7.00B | 7.19B | 6.44B | 6.31B | 5.93B | 7.24B | 7.04B | 6.33B | 6.72B | 5.62B | 4.34B | 3.71B | 3.22B | 2.89B | 2.28B | 2.11B | 1.75B | 1.39B | 1.11B | 875.33M | 498.64M | 377.41M | 307.67M | 183.55M | 152.59M | 142.89M |
| Gross Profit | 4.18B | 5.04B | 4.95B | 4.91B | 4.76B | 4.26B | 3.33B | 2.69B | 2.44B | 3.38B | 2.98B | 1.47B | 1.45B | 1.33B | 1.11B | 897.82M | 733.13M | 509.70M | 515.20M | 674.35M | 675.62M | 263.68M | 198.42M | 210.33M | 174.36M | 131.07M | 126.67M |
| Gross Profit Ratio | 40.34% | 41.86% | 40.79% | 43.27% | 42.97% | 41.78% | 31.52% | 27.67% | 27.83% | 33.48% | 34.67% | 25.28% | 28.17% | 29.25% | 27.76% | 28.22% | 25.83% | 22.53% | 27.03% | 37.89% | 43.56% | 34.59% | 34.46% | 40.60% | 48.72% | 46.21% | 46.99% |
| Research & Development | 391.95M | 428.69M | 372.80M | 401.15M | 903.82M | 639.53M | 439.46M | 411.04M | 445.70M | 417.63M | 396.65M | 326.95M | 202.45M | 192.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 164.99M | 265.94M | 214.26M | 218.88M | 237.60M | 262.30M | 225.42M | 226.48M | 185.40M | 256.73M | 173.27M | 115.91M | 80.91M | 89.77M | 410.61M | 350.58M | 321.31M | 269.05M | 225.71M | 275.08M | 301.17M | 130.57M | 97.61M | 105.63M | 83.64M | 51.61M | 49.43M |
| Selling & Marketing | 2.37B | 2.41B | 2.50B | 2.52B | 2.89B | 2.51B | 1.60B | 1.29B | 1.17B | 1.32B | 1.25B | 377.23M | 281.89M | 281.94M | 232.28M | 188.50M | 113.90M | 82.97M | 82.43M | 62.73M | 93.47M | 42.01M | 36.78M | 26.21M | 21.45M | 20.46M | 10.17M |
| SG&A | 2.53B | 2.67B | 2.71B | 2.74B | 3.13B | 2.78B | 1.82B | 1.52B | 1.36B | 1.58B | 1.43B | 493.14M | 362.80M | 371.72M | 642.89M | 539.08M | 435.21M | 352.02M | 308.14M | 337.81M | 394.63M | 172.59M | 134.39M | 131.84M | 105.09M | 72.07M | 59.61M |
| Other Expenses | 1.17B | 775.64M | 769.17M | 579.96M | 596.32M | -9.16M | 98.02M | 178.24M | 154.22M | 157.16M | 101.17M | 46.12M | 52.47M | 19.88M | 7.86M | 431.16K | -3.09M | 14.70M | 2.40M | -9.08M | -19.78M | -1.27M | 3.81M | 2.19M | -1.42M | -824.00K | -6.06M |
| Operating Expenses | 4.09B | 3.88B | 3.85B | 3.72B | 4.63B | 3.84B | 2.69B | 2.38B | 2.26B | 2.53B | 2.24B | 1.11B | 812.28M | 843.61M | 670.27M | 559.18M | 454.28M | 363.26M | 316.24M | 345.71M | 404.11M | 176.82M | 137.37M | 135.45M | 108.03M | 74.40M | 62.42M |
| Cost & Expenses | 10.28B | 10.88B | 11.04B | 10.16B | 10.94B | 9.77B | 9.93B | 9.42B | 8.59B | 9.25B | 7.86B | 5.45B | 4.52B | 4.06B | 3.56B | 2.84B | 2.56B | 2.12B | 1.71B | 1.45B | 1.28B | 675.46M | 514.78M | 443.12M | 291.58M | 226.99M | 205.31M |
| Interest Income | 20.31M | 26.51M | 21.69M | 32.51M | 16.81M | 20.31M | 24.80M | 29.30M | 35.11M | 22.73M | 16.80M | 23.90M | 8.09M | 3.45M | 0.00 | -0.25 | -0.19 | 1.71M | 2.06M | 2.35M | 981.59K | 1.38M | 3.40M | 1.23M | -0.83 | -0.79 | -0.31 |
| Interest Expense | 215.40M | 283.12M | 345.81M | 420.75M | 525.68M | 401.68M | 308.74M | 303.58M | 241.90M | 214.55M | 134.24M | 77.91M | 59.60M | 52.18M | 77.50M | 82.07M | 64.68M | 53.69M | 36.87M | 25.16M | 21.67M | 18.21M | 12.23M | 10.06M | 6.68M | 1.42M | 5.10M |
| Depreciation & Amortization | 1.04B | 1.05B | 954.33M | 881.31M | 888.30M | 747.17M | 647.31M | 589.90M | 547.25M | 425.96M | 345.75M | 333.08M | 290.73M | 259.80M | 210.97M | 176.98M | 154.48M | 143.42M | 121.91M | 104.34M | 95.72M | 56.92M | 41.61M | 26.11M | 21.58M | 1.62M | 4.89M |
| EBITDA | 1.18B | 2.01B | 1.94B | 2.20B | 1.92B | 1.02B | 1.29B | 1.07B | 985.60M | 1.43B | 1.14B | 726.38M | 950.12M | 743.27M | 639.13M | 515.61M | 433.32M | 303.52M | 327.37M | 424.78M | 348.64M | 146.31M | 111.91M | 94.57M | 87.92M | 56.67M | 64.25M |
| EBITDA Ratio | 11.38% | 17.81% | 17.35% | 19.69% | 31.93% | 11.75% | 13.67% | 12.47% | 11.61% | 14.80% | 13.94% | 13.56% | 19.60% | 17.71% | 16.79% | 16.71% | 15.92% | 13.42% | 17.18% | 23.87% | 22.48% | 19.19% | 19.43% | 19.54% | 24.66% | 20.01% | 23.84% |
| Operating Income | 89.44M | 1.10B | 1.15B | 1.36B | 2.65B | -102.98M | 248.88M | 11.96M | 60.20M | 642.25M | 562.90M | 283.93M | 567.16M | 433.01M | 342.81M | 240.74M | 202.10M | 109.99M | 173.90M | 305.27M | 251.86M | 73.22M | 56.64M | 61.69M | 60.68M | 55.15M | 59.36M |
| Operating Income Ratio | 0.86% | 9.17% | 9.50% | 11.99% | 23.94% | -1.01% | 2.35% | 0.12% | 0.69% | 6.36% | 6.54% | 4.89% | 10.99% | 9.53% | 8.56% | 7.57% | 7.12% | 4.86% | 9.12% | 17.15% | 16.24% | 9.60% | 9.84% | 11.91% | 16.95% | 19.44% | 22.02% |
| Total Other Income/Expenses | -172.31M | -420.34M | -509.23M | -456.95M | -13.76M | -292.43M | 84.79M | 175.27M | 129.29M | 156.18M | 98.63M | 46.11M | 32.64M | -1.72M | -69.99M | -84.47M | -71.46M | -58.31M | -29.27M | -33.04M | -20.61M | -2.03M | 1.43M | -3.82M | -2.89M | -903.89K | -6.26M |
| Income Before Tax | -82.87M | 683.42M | 644.19M | 904.14M | 507.09M | -112.34M | 347.21M | 187.51M | 209.37M | 798.43M | 661.53M | 330.03M | 618.80M | 449.96M | 350.66M | 240.90M | 193.94M | 106.41M | 168.59M | 295.27M | 231.24M | 71.19M | 58.07M | 63.65M | 57.79M | 54.24M | 53.10M |
| Income Before Tax Ratio | -0.80% | 5.68% | 5.31% | 7.96% | 4.58% | -1.10% | 3.28% | 1.93% | 2.39% | 7.91% | 7.69% | 5.69% | 11.99% | 9.90% | 8.76% | 7.57% | 6.83% | 4.70% | 8.85% | 16.59% | 14.91% | 9.34% | 10.08% | 12.29% | 16.15% | 19.12% | 19.70% |
| Income Tax Expense | 14.15M | 192.00M | 133.56M | 180.97M | 183.83M | 124.63M | 115.65M | 125.66M | 83.07M | 246.46M | 154.01M | 60.98M | 103.35M | 75.61M | 71.96M | 40.21M | 51.11M | 24.98M | 49.92M | 76.48M | 57.16M | 18.56M | 9.00M | 8.57M | 7.65M | 6.21M | 283.54 |
| Net Income | -93.17M | 488.86M | 486.89M | 723.17M | 323.27M | -492.47M | 13.57M | -94.43M | 13.57M | 307.90M | 301.86M | 301.29M | 504.08M | 365.76M | 272.25M | 195.32M | 139.67M | 80.34M | 115.88M | 217.25M | 172.16M | 50.10M | 48.54M | 55.78M | 49.46M | 47.30M | 52.56M |
| Net Income Ratio | -0.90% | 4.06% | 4.01% | 6.37% | 2.92% | -4.83% | 0.13% | -0.97% | 0.15% | 3.05% | 3.51% | 5.19% | 9.77% | 8.05% | 6.80% | 6.14% | 4.92% | 3.55% | 6.08% | 12.21% | 11.10% | 6.57% | 8.43% | 10.77% | 13.82% | 16.68% | 19.50% |
| EPS | -0.08 | 0.42 | 0.43 | 0.75 | 0.33 | -0.51 | 0.01 | -0.10 | 0.01 | 0.35 | 0.36 | 0.36 | 0.61 | 0.48 | 0.38 | 0.27 | 0.19 | 0.12 | 0.12 | 0.22 | 0.18 | 0.05 | 0.05 | 0.05 | 0.07 | 0.07 | 0.07 |
| EPS Diluted | -0.08 | 0.42 | 0.43 | 0.75 | 0.33 | -0.51 | 0.01 | -0.10 | 0.01 | 0.35 | 0.36 | 0.36 | 0.61 | 0.48 | 0.38 | 0.27 | 0.19 | 0.12 | 0.12 | 0.22 | 0.18 | 0.05 | 0.05 | 0.05 | 0.07 | 0.07 | 0.07 |
| Weighted Avg Shares Out | 1.16B | 1.15B | 1.13B | 965.53M | 965.53M | 965.53M | 1.36B | 944.28M | 1.36B | 879.70M | 838.49M | 836.92M | 826.36M | 770.02M | 723.59M | 718.42M | 718.57M | 717.00M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M |
| Weighted Avg Shares Out (Dil) | 1.16B | 1.15B | 1.13B | 965.53M | 965.53M | 965.64M | 1.36B | 944.28M | 1.36B | 879.70M | 838.49M | 836.92M | 826.36M | 770.02M | 723.59M | 718.42M | 718.57M | 717.00M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M | 716.80M |
No news found for: 600267.SS
Source: https://incomestatements.info
Category: Stock Reports